Navigation Links
QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
Date:4/20/2009

Primary Endpoints Met; Data Demonstrate MoxDuo(TM) IR Provides Better Tolerability Than Morphine and Oxycodone Alone

SYDNEY, Australia and BEDMINSTER, N.J., April 20 /PRNewswire-FirstCall/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the successful completion of a Phase 3 program pilot study comparing the efficacy and safety profile of MoxDuo(TM) IR against component doses of morphine and oxycodone. Results demonstrated that MoxDuo(TM) IR reduces pain significantly more than its component doses; further, when compared to equianalgesic doses of morphine and oxycodone, MoxDuo(TM) IR produced fewer and less intense side effects. These results confirm 12mg/8mg morphine plus oxycodone combination as the preferred dose for optimal efficacy and tolerability as well as provide sample size guidance for the upcoming Phase 3 Combination Rule study required for NDA submission in 2010.

"Having achieved statistical significance in measures of decreased pain intensity with MoxDuo(TM) IR compared to its component doses, this pilot study exceeded expectations. Completed ahead of schedule and on budget, trial data clearly demonstrated the clinical and commercial value of our patented Dual-Opioid(TM), with the potential to give patients greater tolerability than morphine or oxycodone alone," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "From these data, we are confident that our upcoming Phase 3 Combination Rule study will prove successful."

In this randomized, double blind study of 197 patients at 6 US clinical research sites, MoxDuo(TM) IR was compared to morphine and oxycodone in managing acute pain during the first 24 hours following a scheduled surgical procedure (bunionectomy). When postoperative pain reached a measure of at least "4" (moderate pain, with 10 being the most severe) on the Numerical Pain Rating Scale, patients received either MoxDuo(TM) IR, morp
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
4. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
5. MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test
6. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
7. Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children
8. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
9. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
10. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
11. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,Novembe...visionandPyxisDiscoveryannouncedtoday,thattheyhave...ompanies,services. , Pyxis,sworldclasscomputa...pledwithiThemba,sservicedivisiontoprovidemedicinal...hroughPyxis,internationalclientnetwork.iThembaPha...
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/-...yinvasivetreatmentsforaorticdisorders,announcedtod...eedingsin,thepatentinfringementlawsuitbroughtagain...UnitedStatesDistrictCourtinIndianapolis,Indiana. ,...twhiletheUnitedStatesPatentandTrademarkOffice(USPT...
(Date:11/24/2009)..., POTOMAC,Md.,Nov.24/PRNewswire/--Inadditiont...kihasaddedPhiladelphiajurorstoherThanksgivinggrati...oice.Iamsothankfultothem,"shesaidofMonday,sverdict...ticals. ,, Wisneskiisamong12,000womennationwide...hehormonetherapydrugsPremarinandPrempro.Wisneskian...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Maryland Woman Thankful for Wyeth Verdicts 2Clemson research nets 242 million from NSF to mimic natures probes 9738 1Clemson research nets 242 million from NSF to mimic natures probes 9738 2Bioavailable contaminants come from the Exxon Valdez oil catastrophe 9736 1Bioavailable contaminants come from the Exxon Valdez oil catastrophe 9736 2ClariVein 28TM 29 Catheter for Varicose Veins 3A Clinical Trial Results to be Presented 4922 1ClariVein 28TM 29 Catheter for Varicose Veins 3A Clinical Trial Results to be Presented 4922 2
...III study will evaluate effects of otelixizumab, a...n preservation of endogenous insulin ...il 9, 2008 /PRNewswire/ - Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...rd the initiation of a Phase III study of otelixiz...
...LANTA, April 9, 2008 Dutch biotechnology,company ...on and the South,African Tuberculosis Vaccine Init...ology data from a Phase I Ad35 tuberculosis vaccin... the World" conference (Atlanta,Georgia, April 9 t...uth,Africa and launched in May 2007, is the second...
Other Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6
(Date:11/25/2009)...ALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,al...oilsandsoftwareandCalgaryScientificInc.,aleadingpr...dawebversionofAegis(TM)Breast4DAdvancedVisualizati...ttrulyzero-footprintWebclientbasedmedicalimagingof...atformallowsforzero-footprintaccess-requiringnosof...
(Date:11/25/2009)...Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInstitu...xecutiveleadershipfor2010. ,, ThenewBoardMember...ublicpolicy,law,finance,governmenthealthprograms,e...omesfromawiderangeofpersonalbackgroundsincludingbo...hHIVthemselves,andrepresentingmultipleagegroups. ,...
(Date:11/25/2009)...found evidence of a statistically significant surv...s whose estrogen receptor (ER)-positive tumors had...rine-118 (ER-alpha S118-P), according to a brief c...Journal of the National Cancer Institute . , App...to tamoxifen. Preclinical studies have shown that ...
(Date:11/25/2009)...used to fight rheumatoid arthritis, could help new...WEDNESDAY, Nov. 25 (HealthDay News) -- A drug comm...matoid arthritis now also shows some promise in he...s. , The drug, rituximab (Rituxan), helped pati...n though the disease had destroyed some of their p...
(Date:11/25/2009)...te, CDC sees few signs of trouble with the H1N1 va...y News) -- The ongoing H1N1 swine flu pandemic may... among younger patients, a U.S. health official sa...erious pneumococcal infections around the country,...er for Immunization and Respiratory Diseases at th...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
... Pradesh due to pregnancy related complications, o...//. According to data from the National Fami...te (MMR) in the state stands at 498 - which means ...ut 1.9 million children are born in the state ever...
...rely handicapped by the multiple sclerosis which h.../. After British doctors told her that there...ook a loan of over ?12,000 to go to the Netherland... she is dependent on others to feed her and even t...
...nce of adverse drug reactions in cardiac patients ...those of an East Asian origin//, the results of wh... The results of the present study highlight t...is difference in drug reaction could be attributed...
...l toll on the poultry sector, with losses estimate... and retail sale of chicken have drastically plumm...ses while the NWFP has recorded a loss of around R...ring system has been instituted and all poultry fa...
...lly solved, but scientists are aware that there is...rain to mature during //the "critical period" when...nsory input. Scientists say that the senses of vis... however, because of the pioneering work of Nobel ...
...ntries have banned the import of poultry and lives...cture, when several countries are bothered about t...t is perhaps the right time to understand that bir...h the organisms to have genetic compatibility. Hum...
Other Medicine News:Health News:At Least 25 Women Die Of Maternity Complications In MP Everyday 2Health News:Multiple Sclerosis Patient Seeks Help of Stem Cells 2Health News:Sensory Input Necessary During "Critical Periods" Of Brain Development 2Health News:Sensory Input Necessary During "Critical Periods" Of Brain Development 3Health News:Animal Facts About Bird Flu Transmission 2
ThermoBrite
...trifuge with swinging bucket rotor. ,The MicroPr...h a swinging bucket rotor and optional fixed angle...y of clinical, biomedical, industrial, and biotech...ormation of a "swinging bucket centrifuge in a sma...
..., quiet, high-speed centrifuge. It employs a uniqu...esults in nearly vibration- free operation. Light ...d full breaking in a few seconds. Rotors can easil...sforming the centrifuge from Hematocrit to Urine S...
Silicone Foley
Medicine Products: